Get personalized, coordinated care across Northern California through the Sutter network.
View Patient Resources
Make appointments, message your doctor and more through our patient portal.
Enroll NowOur contributions to medical research and education lead to better healthcare outcomes.
Research at Sutter
Join our robust training programs led by nationally known healthcare leaders.
Explore OpportunitiesExplore the ways we provide innovative, compassionate care through our network.
Learn About Sutter Health
Shape the future of healthcare and build your career within our diverse teams.
Find JobsA Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) (EPCORE DLBCL-2) (M20-621)
Location: REDI (East Bay)
Contact: Chris Tang or 510.204.3428
